Neuromyelitis optica (NMOSD): vizsgálatok itt: Dél-Korea
2 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- No phaseTaking peopleRegistry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
- Where
- Daejeon, Gyeonggi-do, Seoul
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT05966467 - No phaseFut, nem toborozStudy of Ultomiris® (Ravulizumab) Safety in Pregnancy
- Where
- Seoul
- People
- 75 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644